Kimia Alizadeh

Dr. Kimia Alizadeh

Kansas State University, College of Veterinary Medicine, Department of Diagnostic Medicine/Pathobiology, Manhattan, Kansas 66506
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2021 in Viruses
Verified
Journal Article
Open access
PDF file
LCLily Chan
Lily Chan
NKNegar Karimi
Negar Karimi
SMSOLMAZ MOROVATI
SOLMAZ MOROVATI
KAKasra Alizadeh
Kasra Alizadeh
JKJulia Kakish
Julia Kakish
Khalil KarimiKhalil Karimi
Khalil Karimi
A cytokine storm is an abnormal discharge of soluble mediators following an inappropriate inflammatory response that leads to immunopathological events. Cytokine storms can occur after severe infections as well as in non-infectious situations where inflammatory cytokine responses are initiated, then exaggerated, but fail to return to homeostasis. Neutrophils, macrophages, mast cells, and natural killer cells are among the innate leukocytes that contribute to the pathogenesis of cytokine storms. Neutrophils participate as mediators of inflammation and have roles in promoting homeostatic conditions following pathological inflammation. This review highlights the advances in understanding the mechanisms governing neutrophilic inflammation against viral and bacterial pathogens, in cancers, and in autoimmune diseases, and how neutrophils could influence the development of cytokine storm syndromes. Evidence for the destructive potential of neutrophils in their capacity to contribute to the onset of cytokine storm syndromes is presented across a multitude of clinical scenarios. Further, a variety of potential therapeutic strategies that target neutrophils are discussed in the context of suppressing multiple inflammatory conditions.

12 July 2021 in Cells
Verified
Journal Article
Open access
PDF file
BHBahareh Hafezi
Bahareh Hafezi
LCLily Chan
Lily Chan
JKJason Knapp
Jason Knapp
NKNegar Karimi
Negar Karimi
Kimia AlizadehKimia Alizadeh
Kimia Alizadeh
Khalil KarimiKhalil Karimi
Khalil Karimi
Cytokine storm syndrome is a cascade of escalated immune responses disposing the immune system to exhaustion, which might ultimately result in organ failure and fatal respiratory distress. Infection with severe acute respiratory syndrome-coronavirus-2 can result in uncontrolled production of cytokines and eventually the development of cytokine storm syndrome. Mast cells may react to viruses in collaboration with other cells and lung autopsy findings from patients that died from the coronavirus disease that emerged in 2019 (COVID-19) showed accumulation of mast cells in the lungs that was thought to be the cause of pulmonary edema, inflammation, and thrombosis. In this review, we present evidence that a cytokine response by mast cells may initiate inappropriate antiviral immune responses and cause the development of cytokine storm syndrome. We also explore the potential of mast cell activators as adjuvants for COVID-19 vaccines and discuss the medications that target the functions of mast cells and could be of value in the treatment of COVID-19. Recognition of the cytokine storm is crucial for proper treatment of patients and preventing the release of mast cell mediators, as impeding the impacts imposed by these mediators could reduce the severity of COVID-19.

1 September 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
LCLily Chan
Lily Chan
KAKasra Alizadeh
Kasra Alizadeh
Kimia AlizadehKimia Alizadeh
Kimia Alizadeh
FFFatemeh Fazel
Fatemeh Fazel
JKJulia Kakish
Julia Kakish
Byram BridleByram Bridle
Byram Bridle
Influenza viruses have affected the world for over a century, causing multiple pandemics. Throughout the years, many prophylactic vaccines have been developed for influenza; however, these viruses are still a global issue and take many lives. In this paper, we review influenza viruses, associated immunological mechanisms, current influenza vaccine platforms, and influenza infection, in the context of immunocompromised populations. This review focuses on the qualitative nature of immune responses against influenza viruses, with an emphasis on trained immunity and an assessment of the characteristics of the host–pathogen that compromise the effectiveness of immunization. We also highlight innovative immunological concepts that are important considerations for the development of the next generation of vaccines against influenza viruses.

Verified
Journal Article
Open access
PDF file
Lanjing WeiLanjing Wei
Lanjing Wei
HLHuitao Liu
Huitao Liu
Kimia AlizadehKimia Alizadeh
Kimia Alizadeh
MJMaria D. Juarez-Rodriguez
Maria D. Juarez-Rodriguez
RGRoman Ganta
Roman Ganta
Ehrlichia chaffeensis causes human monocytic ehrlichiosis. Little is known about how this and other related tick-borne rickettsia pathogens maintain pH homeostasis in acidified phagosomes and the extracellular milieu. The membrane-bound sodium (cation)/proton antiporters are found in a wide range of organisms aiding pH homeostasis. We recently reported a mutation in an antiporter gene of E. chaffeensis (ECH_0379) which causes bacterial in vivo attenuation. The E. chaffeensis genome contains 10 protein coding sequences encoding for predicted antiporters. We report here that nine of these genes are transcribed during the bacterial growth in macrophages and tick cells. All E. chaffeensis antiporter genes functionally complemented antiporter deficient Escherichia coli. Antiporter activity for all predicted E. chaffeensis genes was observed at pH 5.5, while gene products of ECH_0179 and ECH_0379 were also active at pH 8.0, and ECH_0179 protein was complemented at pH 7.0. The antiporter activity was independently verified for the ECH_0379 protein by proteoliposome diffusion analysis. This is the first description of antiporters in E. chaffeensis and demonstrates that the pathogen contains multiple antiporters with varying biological functions, which are likely important for the pH homeostasis of the pathogen’s replicating and infectious forms.